Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity? / Thierry Deltombe in Annals of physical and rehabilitation medicine, Vol. 62, n°4 (Juillet 2019)  

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 220-224 Titre : Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity? Type de document : texte imprimé Auteurs : Thierry Deltombe ; Thierry Lejeune ; Thierry Gustin Année de publication : 2019 Article en page(s) : p. 220-224 Note générale : https://doi.org/10.1016/j.rehab.2018.07.008 Langues : Anglais (eng) Mots-clés : Hemiplegia  Muscle spasticity  Motor nerve block  Neurotomy  Equinovarus foot Résumé : Objective To discuss the effectiveness, indications, limitations and side effects of botulinum toxin type A and selective neurotomy for treating focal spastic muscle overactivity to help clinicians choose the most appropriate treatment. Methods Expert opinion based on scientific evidence and personal experience. Results Botulinum toxin type A can decrease muscle tone in different types of spastic muscle overactivity, which allows for treating a large variety of spastic patterns with several etiologies. The toxin effect is sometimes insufficient to improve functional outcome and is transient, thereby requiring repeated injections. Selective neurotomy is a permanent surgical treatment of the reflex component of the spastic muscle overactivity (spasticity) that is effective for spastic equinovarus foot. The neurotomy provides a greater and more constant reduction in spasticity. However, the long-lasting effect on the non-reflex muscle overactivity, especially dystonia, is doubted. The effectiveness, clinical indications, advantages, side effects and limitations of both techniques are discussed. Conclusion Botulinum toxin type A has the highest level of evidence and the largest range of indications. However, the botulinum toxin effect is reversible and seems less effective, which supports a permanent surgical treatment such as selective neurotomy, especially for the spastic foot. Further research is needed to compare the effect of botulinum toxin type A and selective neurotomy for the different types of spastic muscle overactivity and clinical patterns. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065718314398 Permalink : ./index.php?lvl=notice_display&id=84126 [article] Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity? [texte imprimé] / Thierry Deltombe ; Thierry Lejeune ; Thierry Gustin . - 2019 . - p. 220-224. https://doi.org/10.1016/j.rehab.2018.07.008 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 220-224 Mots-clés : Hemiplegia  Muscle spasticity  Motor nerve block  Neurotomy  Equinovarus foot Résumé : Objective To discuss the effectiveness, indications, limitations and side effects of botulinum toxin type A and selective neurotomy for treating focal spastic muscle overactivity to help clinicians choose the most appropriate treatment. Methods Expert opinion based on scientific evidence and personal experience. Results Botulinum toxin type A can decrease muscle tone in different types of spastic muscle overactivity, which allows for treating a large variety of spastic patterns with several etiologies. The toxin effect is sometimes insufficient to improve functional outcome and is transient, thereby requiring repeated injections. Selective neurotomy is a permanent surgical treatment of the reflex component of the spastic muscle overactivity (spasticity) that is effective for spastic equinovarus foot. The neurotomy provides a greater and more constant reduction in spasticity. However, the long-lasting effect on the non-reflex muscle overactivity, especially dystonia, is doubted. The effectiveness, clinical indications, advantages, side effects and limitations of both techniques are discussed. Conclusion Botulinum toxin type A has the highest level of evidence and the largest range of indications. However, the botulinum toxin effect is reversible and seems less effective, which supports a permanent surgical treatment such as selective neurotomy, especially for the spastic foot. Further research is needed to compare the effect of botulinum toxin type A and selective neurotomy for the different types of spastic muscle overactivity and clinical patterns. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065718314398 Permalink : ./index.php?lvl=notice_display&id=84126

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

---

1 (1 - 1 / 1)